Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

Lutz, M. B., Kukutsch, N. A., Ogilvie, A. L. J., Rößner, S., Koch, F., Romani, N., & Schuler, G. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00204-x · Cited by 2,972 · see citing works

Sample criteria for testing outlying observations

Grubbs, F. E. (1950) · The Annals of Mathematical Statistics · doi:10.1214/aoms/1177729885 · Cited by 1,631 · see citing works

IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge

Khader, S. A., Bell, G. K., Pearl, J. E., Fountain, J. J., Rangel‐Moreno, J., Cilley, G. E., Shen, F., Eaton, S. M., Gaffen, S. L., Swain, S. L., et al. (2007) · Nature Immunology · doi:10.1038/ni1449 · Cited by 1,442 · see citing works

Exploiting lymphatic transport and complement activation in nanoparticle vaccines

Reddy, S. T., van der Vlies, A. J., Simeoni, E., Angeli, V., Randolph, G. J., O’Neil, C. P., Lee, L. K., Swartz, M. A., & Hubbell, J. A. (2007) · Nature Biotechnology · doi:10.1038/nbt1332 · Cited by 1,355 · see citing works

Global tuberculosis control 2010

Behera, D. (2012) · The Indian Journal of Medical Research · Cited by 1,262 · see citing works

Induction and effector functions of TH17 cells

Bettelli, E., Korn, T., Oukka, M., & Kuchroo, V. K. (2008) · Nature · doi:10.1038/nature07036 · Cited by 1,207 · see citing works

The success and failure of BCG — implications for a novel tuberculosis vaccine

Andersen, P. L., & Doherty, T. M. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1211 · Cited by 791 · see citing works

Immune Control of Tuberculosis by IFN-γ-Inducible LRG-47

MacMicking, J. D., Taylor, G. A., & McKinney, J. D. (2003) · Science · doi:10.1126/science.1088063 · Cited by 685 · see citing works

Materials engineering for immunomodulation

Hubbell, J. A., Thomas, S. N., & Swartz, M. A. (2009) · Nature · doi:10.1038/nature08604 · Cited by 565 · see citing works

Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome

Sharp, F. A., Ruane, D., Claass, B., Creagh, E. M., Harris, J., Malyala, P., Singh, M., O’Hagan, D. T., Pétrilli, V., Tschopp, J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804897106 · Cited by 536 · see citing works

Distinct, Specific IL-17- and IL-22-Producing CD4+ T Cell Subsets Contribute to the Human Anti-Mycobacterial Immune Response

Scriba, T. J., Kalsdorf, B., Abrahams, D. A., Isaacs, F., Hofmeister, J., Black, G. F., Hassan, H. Y., Wilkinson, R. J., Walzl, G., Gelderbloem, S., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1962 · Cited by 410 · see citing works

Inflammasomes: current understanding and open questions

Bauernfeind, F. G., Ablasser, A., Bartok, E., Kim-Hellmuth, S., Schmid-Burgk, J. L., Cavlar, T., & Hornung, V. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0567-4 · Cited by 356 · see citing works

IL-17 and Th17 cells in tuberculosis

Torrado, E., & Cooper, A. M. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.10.004 · Cited by 327 · see citing works

The presence of multifunctional, high-cytokine-producing Th1 cells in the lung, but not spleen, correlates with protection against Mycobacterium tuberculosis aerosol challenge in mice

Forbes, E. K., Sander, C., Ronan, E. O., McShane, H., Hill, A., Beverley, P., & Tchilian, E. (2008) · Journal of Immunology · doi:10.4049/jimmunol.181.7.4955 · Cited by 307 · see citing works

New vaccines for tuberculosis

Kaufmann, S. H. E., Hussey, G. D., & Lambert, P. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60393-5 · Cited by 297 · see citing works

Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis

Mittrücker, H., Steinhoff, U., Köhler, A. C., Krause, M., Lazar, D., Mex, P., Miekley, D., & Kaufmann, S. H. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703510104 · Cited by 283 · see citing works

Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation

Hirosue, S., Kourtis, I. C., van der Vlies, A. J., Hubbell, J. A., & Swartz, M. A. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.09.077 · Cited by 234 · see citing works

IL-17–producing T cells in lung immunity and inflammation

Nembrini, C., Marsland, B. J., & Köpf, M. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.03.033 · Cited by 210 · see citing works

Modified vaccinia Ankara‐expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells

Scriba, T. J., Tameris, M. D., Mansoor, N., Smit, E., van der Merwe, L., Isaacs, F., Keyser, A. T., Moyo, S., Brittain, N. J., Lawrie, A. M., et al. (2009) · European Journal of Immunology · doi:10.1002/eji.200939754 · Cited by 190 · see citing works

CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases

Klinman, D. M., Klaschik, S., Sato, T., & Tross, D. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.12.012 · Cited by 181 · see citing works

Single step protocol to purify recombinant proteins with low endotoxin contents

Reichelt, P., Schwarz, C., & Donzeau, M. (2005) · Protein Expression and Purification · doi:10.1016/j.pep.2005.09.027 · Cited by 166 · see citing works

Nanobead-based interventions for the treatment and prevention of tuberculosis

Griffiths, G., Nyström, B., Sable, S. B., & Khuller, G. K. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2437 · Cited by 164 · see citing works

Engineering complement activation on polypropylene sulfide vaccine nanoparticles

Thomas, S. N., van der Vlies, A. J., O’Neil, C. P., Reddy, S. T., Yu, S. S., Giorgio, T. D., Swartz, M. A., & Hubbell, J. A. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.11.037 · Cited by 127 · see citing works

Synthesis of Pyridyl Disulfide-Functionalized Nanoparticles for Conjugating Thiol-Containing Small Molecules, Peptides, and Proteins

van der Vlies, A. J., O’Neil, C. P., Hasegawa, U., Hammond, N. A., & Hubbell, J. A. (2010) · Bioconjugate Chemistry · doi:10.1021/bc9004443 · Cited by 111 · see citing works

Intranasal Immunization Promotes Th17 Immune Responses

Zygmunt, B. M., Rharbaoui, F., Groebe, L., & Guzmán, C. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901144 · Cited by 88 · see citing works

A key role for lung‐resident memory lymphocytes in protective immune responses after BCG vaccination

Connor, L. M., Harvie, M., Rich, F. J., Quinn, K. M., Brinkmann, V., Gros, G. S. L., & Kirman, J. R. (2010) · European Journal of Immunology · doi:10.1002/eji.200940279 · Cited by 76 · see citing works

PPS nanoparticles as versatile delivery system to induce systemic and broad mucosal immunity after intranasal administration

Stano, A., van der Vlies, A. J., Martino, M. M., Swartz, M. A., Hubbell, J. A., & Simeoni, E. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.11.010 · Cited by 73 · see citing works

Enhanced Production of Recombinant Mycobacterium tuberculosis Antigens in Escherichia coli by Replacement of Low-Usage Codons

Lakey, D. L., Voladri, R. K. R., Edwards, K. M., Hager, C., Samten, B., Wallis, R. S., Barnes, P. F., & Kernodle, D. S. (2000) · Infection and Immunity · doi:10.1128/iai.68.1.233-238.2000 · Cited by 67 · see citing works

Should a new tuberculosis vaccine be administered intranasally?

Källenius, G., Pawlowski, A., Brandtzæg, P., & Svenson, S. B. (2007) · Tuberculosis · doi:10.1016/j.tube.2006.12.006 · Cited by 60 · see citing works

Essential and synergistic roles of IL1 and IL6 in human Th17 differentiation directed by TLR ligand-activated dendritic cells

Benwell, R. K., & Lee, D. R. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.09.013 · Cited by 60 · see citing works

Vaccine strategies against tuberculosis

McShane, H. (2009) · Swiss Medical Weekly · doi:10.4414/smw.2009.12374 · Cited by 34 · see citing works

Prospects for a new, safer and more effective TB vaccine

Hawkridge, T., & Mahomed, H. (2010) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2010.09.013 · Cited by 32 · see citing works

Application of an electronic counter in the evaluation of significant bacteriuria.

Jp, T., Wa, B., & Ke, M. (1962) · PubMed · Cited by 7 · see citing works

From Sewer to Saviour—Targeting the Lymphatic System to Promote Drug Exposure and Activity

Trevaskis, N. L., Kaminskas, L. M., & Porter, C. J. H. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4608 · Cited by 654 · see citing works

Engineering synthetic vaccines using cues from natural immunity

Irvine, D. J., Swartz, M. A., & Szeto, G. L. (2013) · Nature Materials · doi:10.1038/nmat3775 · Cited by 596 · see citing works

Nanotechnology approaches for global infectious diseases

Kirtane, A. R., Verma, M., Karandikar, P., Furin, J., Langer, R., & Traverso, G. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00866-8 · Cited by 520 · see citing works

Nanoparticle Vaccines Against Infectious Diseases

Pati, R., Shevtsov, M. A., & Sonawane, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02224 · Cited by 515 · see citing works

Nanoparticle diffusion in respiratory mucus from humans without lung disease

Schuster, B. S., Suk, J. S., Woodworth, G. F., & Hanes, J. S. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.064 · Cited by 468 · see citing works

Nanotechnology for COVID-19: Therapeutics and Vaccine Research

Chauhan, G., Madou, M. J., Kalra, S., Chopra, V., Ghosh, D., & Martinez-Chapa, S. O. (2020) · ACS Nano · doi:10.1021/acsnano.0c04006 · Cited by 382 · see citing works

COVID-19 vaccines: The status and perspectives in delivery points of view

Chung, J. Y., Thone, M. N., & Kwon, Y. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.011 · Cited by 375 · see citing works

Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response

Thomas, S. N., Vokali, E., Lund, A. W., Hubbell, J. A., & Swartz, M. A. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.003 · Cited by 310 · see citing works

Immunological properties of gold nanoparticles

Dykman, L. A., & Khlebtsov, N. G. (2016) · Chemical Science · doi:10.1039/c6sc03631g · Cited by 261 · see citing works

Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose

de Titta, A., Ballester, M. C., Julier, Z., Nembrini, C., Jeanbart, L., van der Vlies, A. J., Swartz, M. A., & Hubbell, J. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313152110 · Cited by 254 · see citing works

Engineering Approaches to Immunotherapy

Swartz, M. A., Hirosue, S., & Hubbell, J. A. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003763 · Cited by 223 · see citing works

Generation of Effector Memory T Cell–Based Mucosal and Systemic Immunity with Pulmonary Nanoparticle Vaccination

Li, A. V., Moon, J. J., Abraham, W. D., Suh, H., Elkhader, J. A., Seidman, M. A., Yen, M., Im, E., Foley, M. H., Barouch, D. H., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006516 · Cited by 187 · see citing works

Polyfunctional CD4+ T Cells As Targets for Tuberculosis Vaccination

Lewinsohn, D. A., Lewinsohn, D. M., & Scriba, T. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01262 · Cited by 176 · see citing works

New perspectives in nanomedicine

Thorley, A. J., & Tetley, T. D. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.06.008 · Cited by 171 · see citing works

Biomaterial Strategies for Immunomodulation

Hotaling, N. A., Tang, L., Irvine, D. J., & Babensee, J. E. (2015) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071813-104814 · Cited by 170 · see citing works

Applications of nanomaterials as vaccine adjuvants

Zhu, M., Wang, R., & Nie, G. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.29589 · Cited by 162 · see citing works

Mucosal Immunization with a pH-Responsive Nanoparticle Vaccine Induces Protective CD8+ Lung-Resident Memory T Cells

Knight, F. C., Gilchuk, P., Kumar, A., Becker, K. W., Sevimli, S., Jacobson, M. E., Suryadevara, N., Wang-Bishop, L., Boyd, K., Crowe, J., et al. (2019) · ACS Nano · doi:10.1021/acsnano.9b00326 · Cited by 113 · see citing works

Peripherally Administered Nanoparticles Target Monocytic Myeloid Cells, Secondary Lymphoid Organs and Tumors in Mice

Kourtis, I. C., Hirosue, S., de Titta, A., Kontos, S., Stegmann, T., Hubbell, J. A., & Swartz, M. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061646 · Cited by 127 · see citing works

Synthetic nanovaccines for immunotherapy

Luo, M., Samandi, L. Z., Wang, Z., Chen, Z. J., & Gao, J. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.033 · Cited by 124 · see citing works

Tunable T cell immunity towards a protein antigen using polymersomes vs. solid-core nanoparticles

Stano, A., Scott, E. A., Dane, K. Y., Swartz, M. A., & Hubbell, J. A. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.02.024 · Cited by 119 · see citing works

Advances and Opportunities in Nanoparticle‐ and Nanomaterial‐Based Vaccines against Bacterial Infections

Lin, L. C. W., Chattopadhyay, S., Lin, J., & Hu, C. J. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701395 · Cited by 108 · see citing works

Nanocarriers Targeting Dendritic Cells for Pulmonary Vaccine Delivery

Kunda, N. K., Somavarapu, S., Gordon, S. B., Hutcheon, G. A., & Saleem, I. Y. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0891-5 · Cited by 98 · see citing works

Implications of Lymphatic Transport to Lymph Nodes in Immunity and Immunotherapy

Thomas, S. N., Rohner, N. A., & Edwards, E. E. (2016) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-101515-014413 · Cited by 84 · see citing works

Nanoparticle size influences the magnitude and quality of mucosal immune responses after intranasal immunization

Stano, A., Nembrini, C., Swartz, M. A., Hubbell, J. A., & Simeoni, E. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.10.050 · Cited by 84 · see citing works

Nanotechnology Against The Novel Coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2): Diagnosis, Treatment, Therapy and Future Perspectives

Rashidzadeh, H., Danafar, H., Rahimi, H., Mozafari, F., Salehiabar, M., Rahmati, M.-A., Rahamouz-Haghighi, S., Mousazadeh, N., Mohammadi, A., Ertaş, Y. N., et al. (2021) · Nanomedicine · doi:10.2217/nnm-2020-0441 · Cited by 76 · see citing works

Simple nanoliposomes encapsulating Lycium barbarum polysaccharides as adjuvants improve humoral and cellular immunity in mice

Bo, R., Sun, Y., Zhou, S., Ou, N., Gu, P., Liu, Z., Hu, Y., Liu, J., & Wang, D. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s136820 · Cited by 72 · see citing works

Design of nanomaterial based systems for novel vaccine development

Liu, Y., Li, W., Kirberger, M., Liao, W., & Ren, J. (2016) · Biomaterials Science · doi:10.1039/c5bm00507h · Cited by 70 · see citing works

How can nanoparticles contribute to antituberculosis therapy?

Costa-Gouveia, J., Aínsa, J. A., Brodin, P. M., & Lucía, A. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.01.011 · Cited by 68 · see citing works

Devices and formulations for pulmonary vaccination

Tonnis, W. F., Lexmond, A. J., Frijlink, H. W., de Boer, A. H., & Hinrichs, W. L. J. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.810622 · Cited by 66 · see citing works

Airway delivery of peptides and proteins using nanoparticles

Dombu, C. Y., & Betbeder, D. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.08.070 · Cited by 64 · see citing works

Potent Lymphatic Translocation and Spatial Control Over Innate Immune Activation by Polymer–Lipid Amphiphile Conjugates of Small‐Molecule TLR7/8 Agonists

Vrieze, J. D., Louage, B., Deswarte, K., Zhong, Z., Coen, R. D., Herck, S. V., Nuhn, L., Frich, C. K., Zelikin, A. N., Lienenklaus, S., et al. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201905687 · Cited by 64 · see citing works

Biomaterials Strategies for Generating Therapeutic Immune Responses

Kelly, S. H., Shores, L. S., Votaw, N. L., & Collier, J. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.009 · Cited by 51 · see citing works

Novel adjuvant formulations for delivery of anti-tuberculosis vaccine candidates

Agger, E. M. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.012 · Cited by 60 · see citing works

Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges

Stylianou, E., Paul, M. J., Reljić, R., & McShane, H. (2019) · Expert Review of Vaccines · doi:10.1080/14760584.2019.1692657 · Cited by 59 · see citing works

The expanding role of aerosols in systemic drug delivery, gene therapy and vaccination: an update

Laube, B. L. (2014) · Translational Respiratory Medicine · doi:10.1186/2213-0802-2-3 · Cited by 58 · see citing works

Vaccine nanocarriers: Coupling intracellular pathways and cellular biodistribution to control CD4 vs CD8 T cell responses

Rincón-Restrepo, M., Mayer, A. T., Hauert, S., Bonner, D. K., Phelps, E. A., Hubbell, J. A., Swartz, M. A., & Hirosue, S. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.03.047 · Cited by 55 · see citing works

Mucosal immunization with PspA (Pneumococcal surface protein A)-adsorbed nanoparticles targeting the lungs for protection against pneumococcal infection

Rodrigues, T. C., Oliveira, M. L. S., Schanoski, A. S., Rico, S. L. C., Poschinger-Figueiredo, D., Gonçalves, V. M., Ferreira, D. M., Kunda, N. K., Saleem, I. Y., & Miyaji, E. N. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191692 · Cited by 55 · see citing works

Pulmonary Vaccine Delivery: A Realistic Approach?

Tonnis, W. F., Kersten, G. F. A., Frijlink, H. W., Hinrichs, W. L. J., de Boer, A. H., & Amorij, J. (2012) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2011.0931 · Cited by 54 · see citing works

Nanoparticle conjugation enhances the immunomodulatory effects of intranasally delivered CpG in house dust mite-allergic mice

Ballester, M. C., Jeanbart, L., de Titta, A., Nembrini, C., Marsland, B. J., Hubbell, J. A., & Swartz, M. A. (2015) · Scientific Reports · doi:10.1038/srep14274 · Cited by 49 · see citing works

A high-throughput nanoimmunoassay chip applied to large-scale vaccine adjuvant screening

Garcia-Cordero, J. L., Nembrini, C., Stano, A., Hubbell, J. A., & Maerkl, S. J. (2013) · Integrative Biology · doi:10.1039/c3ib20263a · Cited by 48 · see citing works

Aerosol pulmonary immune engineering

Sudduth, E. R., Trautmann-Rodriguez, M., Gill, N. A., Bomb, K., & Fromen, C. A. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114831 · Cited by 49 · see citing works

Carrier molecules for use in veterinary vaccines

Gerdts, V., Mutwiri, G., Richards, J. M., den Hurk, S. V. D. L., & Potter, A. A. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.11.067 · Cited by 44 · see citing works

Targeted immunomodulation using antigen‐conjugated nanoparticles

McCarthy, D. P., Hunter, Z. N., Chackerian, B., Shea, L. D., & Miller, S. D. (2014) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1263 · Cited by 45 · see citing works

Roles of Mucosal Immunity againstMycobacterium tuberculosisInfection

Li, W., Deng, G., Li, M., Liu, X., & Wang, Y. (2012) · Tuberculosis Research and Treatment · doi:10.1155/2012/791728 · Cited by 43 · see citing works

Nanomaterials in the Prevention, Diagnosis, and Treatment of Mycobacterium Tuberculosis Infections

Xu, K., Liang, Z. C., Ding, X., Hu, H., Liu, S., Nurmik, M., Bi, S., Hu, F.-S., Ji, Z., Ren, J., et al. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700509 · Cited by 44 · see citing works

Polymer micelles with pyridyl disulfide-coupled antigen travel through lymphatics and show enhanced cellular responses following immunization

Eby, J. K., Dane, K. Y., O’Neil, C. P., Hirosue, S., Swartz, M. A., & Hubbell, J. A. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.06.007 · Cited by 40 · see citing works

Robust mucosal and systemic responses against HTLV-1 by delivery of multi-epitope vaccine in PLGA nanoparticles

Kabiri, M., Sankian, M., Sadri, K., & Tafaghodi, M. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.11.003 · Cited by 38 · see citing works

Nanoparticle Conjugation of Human Papillomavirus 16 E7-long Peptides Enhances Therapeutic Vaccine Efficacy against Solid Tumors in Mice

Galliverti, G., Tichet, M., Domingos‐Pereira, S., Hauert, S., Nardelli‐Haefliger, D., Swartz, M. A., Hanahan, D., & Wullschleger, S. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0166 · Cited by 36 · see citing works

A recombinant adenovirus expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis elicits strong antigen-specific immune responses in mice

Li, W., Deng, G., Li, M., Jin, Z., Zhao, L., Liu, X., & Wang, Y. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.06.007 · Cited by 35 · see citing works

Nebulized oil-in-water nanoemulsion mists for pulmonary delivery: development, physico-chemical characterization andin vitroevaluation

Nesamony, J., Shah, I. S., Kalra, A. V., & Jung, R. (2013) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2013.814065 · Cited by 35 · see citing works

Nanoscale Peptide Self-assemblies Boost BCG-primed Cellular Immunity Against Mycobacterium tuberculosis

Chesson, C. B., Huante, M. B., Nusbaum, R. J., Walker, A. G., Clover, T. M., Jagannath, C., Endsley, J. J., & Rudra, J. S. (2018) · Scientific Reports · doi:10.1038/s41598-018-31089-y · Cited by 35 · see citing works

Intrapulmonary Delivery of CpG Microparticles Eliminates Lung Tumors

Sato, T., Shimosato, T., Ueda, A., Ishigatsubo, Y., & Klinman, D. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0401 · Cited by 28 · see citing works

Decreased IL-17 during treatment of sputum smear-positive pulmonary tuberculosis due to increased regulatory T cells and IL-10

Xu, L., Cui, G., Jia, H., Zhu, Y., Ding, Y., Chen, J., Lu, C., Ye, P., Gao, H., Li, L., et al. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0909-6 · Cited by 34 · see citing works

Mucosal Vaccines: Where Do We Stand?

Kraehenbühl, J.-P., & Neutra, M. R. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113136660186 · Cited by 34 · see citing works

HBHA vaccination may require both Th1 and Th17 immune responses to protect mice against tuberculosis

Verwaerde, C., Debrie, A., Dombu, C. Y., Legrand, D., Raze, D., Lecher, S., Betbeder, D., & Locht, C. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.09.024 · Cited by 32 · see citing works

Mycobacterium Tuberculosis and Interactions with the Host Immune System: Opportunities for Nanoparticle Based Immunotherapeutics and Vaccines

Bekale, R. B., du Plessis, S., Hsu, N., Sharma, J. R., Sampson, S. L., Jacobs, M., Meyer, M., Morse, G. D., & Dube, A. (2018) · Pharmaceutical Research · doi:10.1007/s11095-018-2528-9 · Cited by 32 · see citing works

Targeting the deep lungs, Poloxamer 407 and a CpG oligonucleotide optimize immune responses to Mycobacterium tuberculosis antigen 85A following pulmonary delivery

Todoroff, J., Učakar, B., Inglese, M., Vandermarliere, S., Fillée, C., Renauld, J., Huygen, K., & Rita Vanbever, A. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.11.020 · Cited by 31 · see citing works

Potential of nanotechnology as a delivery platform against tuberculosis: Current research review

Choudhary, S., & Devi, V. K. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.035 · Cited by 28 · see citing works

Epitope‐specific CD4+, but not CD8+, T‐cell responses induced by recombinant influenza A viruses protect against Mycobacterium tuberculosis infection

Flórido, M., Pillay, R., Gillis, C. M., Xia, Y., Turner, S. J., Triccas, J. A., Stambas, J., & Britton, W. J. (2014) · European Journal of Immunology · doi:10.1002/eji.201444954 · Cited by 28 · see citing works

Potential of polymeric particles as future vaccine delivery systems/adjuvants for parenteral and non-parenteral immunization against tuberculosis: A systematic review.

Khademi, F., Derakhshan, M., Avarvand, A. Y., & Tafaghodi, M. (2018) · Europe PMC (PubMed Central) · doi:10.22038/ijbms.2017.22059.5648 · Cited by 28 · see citing works

Nanoparticle-Conjugated Toll-Like Receptor 9 Agonists Improve the Potency, Durability, and Breadth of COVID-19 Vaccines

Ou, B. S., Baillet, J., Picece, V. C. T. M., Gale, E. C., Powell, A. E., Saouaf, O. M., Yan, J., Nejatfard, A., Hernandez, H. L., & Appel, E. A. (2024) · ACS Nano · doi:10.1021/acsnano.3c09700 · Cited by 27 · see citing works

Mesoporous Silica Nanoparticles as a Potential Platform for Vaccine Development against Tuberculosis

Montalvo-Quirós, S., Vallet‐Regí, M., Palacios, A., Anguíta, J., Prados‐Rosales, R., González, B., & Luque-Garcia, J. L. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121218 · Cited by 24 · see citing works

Engineering Vaccines for Tissue-Resident Memory T Cells

Knight, F. C., & Wilson, J. T. (2021) · Advances in Therapy · doi:10.1002/adtp.202000230 · Cited by 22 · see citing works

Development of novel carrier(s) mediated tuberculosis vaccine: More than a tour de force

Garg, N. K., Dwivedi, P., Jain, A., Tyagi, S., Sahu, T., & Tyagi, R. K. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.05.028 · Cited by 23 · see citing works

Recombinant Ag85B vaccine by taking advantage of characteristics of human parainfluenza type 2 virus vector showed Mycobacteria-specific immune responses by intranasal immunization

Watanabe, K., Matsubara, A., Kawano, M., Mizuno, S., Okamura, T., Tsujimura, Y., Inada, H., Nosaka, T., Matsuo, K., & Yasutomi, Y. (2014) · Vaccine · doi:10.1016/j.vaccine.2013.11.108 · Cited by 23 · see citing works

Selective drug deposition in lungs through pulmonary drug delivery system for effective management of drug-resistant TB

Sankhe, K., Khan, T., Bhavsar, C., Momin, M., & Omri, A. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1609937 · Cited by 18 · see citing works

Nanotoxoids: Biomimetic Nanoparticle Vaccines against Infections

Guo, Z., Kubiatowicz, L. J., Fang, R. H., & Zhang, L. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100072 · Cited by 22 · see citing works

A Cationic Micelle Complex Improves CD8+ T Cell Responses in Vaccination Against Unmodified Protein Antigen

Brubaker, C. E., Panagiotou, V., Demurtas, D., Bonner, D. K., Swartz, M. A., & Hubbell, J. A. (2015) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5b00456 · Cited by 20 · see citing works

Advancements in Nanoparticle-Based Adjuvants for Enhanced Tuberculosis Vaccination: A Review

Wang, J., Zhao, Z., Wang, Q., Shi, J., Wong, D. W., & Cheung, J. C. (2024) · Vaccines · doi:10.3390/vaccines12121335 · Cited by 19 · see citing works

Nanocarriers for Respiratory Diseases Treatment: Recent Advances and Current Challenges

Trapani, A., Gioia, S. D., Castellani, S., Carbone, A., Cavallaro, G., Trapani, G., & Conese, M. (2014) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026614666140329225817 · Cited by 19 · see citing works

Advanced Nanosystems and Emerging Therapies: Innovations in Tuberculosis Treatment and Drug Resistance

Sharma, A., Sharma, V., Sharma, S., Sharma, S., Sharma, M., & Sivanesan, I. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17111459 · Cited by 16 · see citing works

Comparative efficacy analysis of anti-microbial peptides, LL-37 and indolicidin upon conjugation with CNT, in human monocytes

Pradhan, B., Guha, D., Murmu, K. C., Sur, A., Ray, P., Das, D., & Aich, P. (2017) · Journal of Nanobiotechnology · doi:10.1186/s12951-017-0278-1 · Cited by 16 · see citing works

Current advancements in nanoparticles for vaccines and drug delivery for the treatment of tuberculosis

Sharma, D. K. (2025) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2025.107138 · Cited by 15 · see citing works

Advancing Immunotherapeutic Vaccine Strategies Against Pulmonary Tuberculosis

Afkhami, S., Villela, A. D., D’Agostino, M. R., Jeyanathan, M., Gillgrass, A. E., & Xing, Z. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.557809 · Cited by 15 · see citing works

Vaccination with mycobacterial lipid loaded nanoparticle leads to lipid antigen persistence and memory differentiation of antigen-specific T cells

Morgun, E., Zhu, J. Y., Almunif, S., Bobbala, S. K. R., Aguilar, M. S., Wang, J., Conner, K., Cui, Y., Cao, L., Seshadri, C., et al. (2023) · eLife · doi:10.7554/elife.87431 · Cited by 14 · see citing works

In vivo imaging of T cells loaded with gold nanoparticles: a pilot study

Li, H., Diaz, L., Lee, D. Y., Cui, L., Liang, X., & Cheng, Y. (2013) · La radiologia medica · doi:10.1007/s11547-013-0335-2 · Cited by 14 · see citing works

Strategy to Enhance Dendritic Cell‐Mediated DNA Vaccination in the Lung

Kim, Y. C., Hsueh, H. T., Kim, N., Rodriguez, J., Leo, K. T., Rao, D., West, N. E., Hanes, J. S., & Suk, J. S. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202000228 · Cited by 12 · see citing works

A comprehensive review on efficient approaches for combating coronaviruses

Pouresmaieli, M., Ekrami, E., Akbari, A., Noorbakhsh, N., Moghadam, N. B., & Mamoudifard, M. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112353 · Cited by 12 · see citing works

Development of a New Tuberculosis Vaccine: Is there Value in the Mucosal Approach?

Diogo, G. R., & Reljić, R. (2014) · Immunotherapy · doi:10.2217/imt.14.62 · Cited by 11 · see citing works

Nasal mRNA Nanovaccine with Key Activators of Dendritic and MAIT Cells for Effective Against Lung Tumor Metastasis in Mice Model

Li, A., Cai, X., Li, D., Yu, Y., Liu, C., Shen, J., You, J., Qiao, J., & Wang, F. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s479741 · Cited by 10 · see citing works

Transgene Delivery to Human Induced Pluripotent Stem Cells Using Nanoparticles

Yamoah, M., Thai, P. N., & Zhang, X.-D. (2021) · Pharmaceuticals · doi:10.3390/ph14040334 · Cited by 10 · see citing works

Strategy to Enhance Dendritic Cell‐Mediated DNA Vaccination in the Lung

Kim, Y. C., Hsueh, H. T., Kim, N., Rodriguez, J., Leo, K. T., Rao, D., West, N. E., Hanes, J. S., & Suk, J. S. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000013 · Cited by 9 · see citing works

CNA-loaded PLGA nanoparticles improve humoral response againstS. aureus-mediated infections in a mouse model: subcutaneous vs. nasal administration strategy

Genta, I., Colonna, C., Conti, B., Caliceti, P., Salmaso, S., Speziale, P., Pietrocola, G., Chiesa, E., Modena, T., & Dorati, R. (2016) · Journal of Microencapsulation · doi:10.1080/02652048.2016.1260661 · Cited by 9 · see citing works

Novel Nanotechnology Based Delivery Systems for Chemotherapy and Prophylaxis of Tuberculosis

Jain, R., Savla, H. M., Naik, I., Maniar, J., Punjabi, K., Vaidya, S. P., & Menon, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813351-4.00034-1 · Cited by 9 · see citing works

Correlates of Protection from Tuberculosis

Álvarez, M. P. P., Marshall, J. L., & Tanner, R. (2023) · Springer eBooks · doi:10.1007/978-3-031-24355-4_6 · Cited by 8 · see citing works

Gold nanoparticle-based strategies against SARS-CoV-2: A review

Rasmi, Y., Kırboğa, K. K., Khan, J., Gupta, E., Attia, F. M., Yallapu, M. M., & Pilaquinga, F. (2023) · REVIEWS ON ADVANCED MATERIALS SCIENCE · doi:10.1515/rams-2023-0105 · Cited by 8 · see citing works

Tuberculosis vaccine developments and efficient delivery systems: A comprehensive appraisal

Hosseinpour, R., Hasani, A., Baradaran, B., Abdolalizadeh, J., Salehi, R., Hasani, A., Nabizadeh, E., Yekani, M., Hasani, R., Kafil, H. S., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26193 · Cited by 8 · see citing works

Development of Adjuvanted Solid Fat Nanoemulsions for Pulmonary Hepatitis B Vaccination

Minz, S., & Pandey, R. S. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.02.007 · Cited by 7 · see citing works

Considerations for the Human Health Implications of Nanotheranostics

Burgum, M. J., Evans, S. J., Jenkins, G. J. S., Doak, S. H., & Clift, M. J. D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813339-2.00010-4 · Cited by 6 · see citing works

Nanoparticle Vaccines Against Infectious Diseases

(2020) · Frontiers research topics · doi:10.3389/978-2-88963-327-2 · Cited by 6 · see citing works

Pulmonary Administration of Subunit Vaccines

Tonnis, W. F., Huckriede, A. L. W., Hinrichs, W. L. J., & Frijlink, H. W. (2014) · Advances in delivery science and technology · doi:10.1007/978-1-4939-1417-3_16 · Cited by 5 · see citing works

Amphiphile Polymer‐Lipidkonjugate zur potenten lymphatischen Anreicherung von TLR7/8‐Agonisten ermöglichen eine örtlich begrenzte Aktivierung des angeborenen Immunsystems

Vrieze, J. D., Louage, B., Deswarte, K., Zhong, Z., Coen, R. D., Herck, S. V., Nuhn, L., Frich, C. K., Zelikin, A. N., Lienenklaus, S., et al. (2019) · Angewandte Chemie · doi:10.1002/ange.201905687 · Cited by 5 · see citing works

Intranasal delivery of nanoparticle-based vaccine increases protection against S. pneumoniae

Mott, B., Thamake, S. I., Vishwanatha, J. K., & Jones, H. P. (2013) · Journal of Nanoparticle Research · doi:10.1007/s11051-013-1646-x · Cited by 5 · see citing works

Reactivation of immune responses against Mycobacterium tuberculosis by boosting with the CpG oligomer in aged mice primarily vaccinated with Mycobacterium bovis BCG

Taniguchi, K., Takii, T., Yamamoto, S., Maeyama, J., Iho, S., Maruyama, M., Iizuka, N., Ozeki, Y., Matsumoto, S., Hasegawa, T., et al. (2013) · Immunity & Ageing · doi:10.1186/1742-4933-10-25 · Cited by 5 · see citing works

Goals and strategies in vaccine development against tuberculosis

Konjengbam, B. D., Meitei, H. N., Pandey, A., & Haobam, R. (2025) · Molecular Immunology · doi:10.1016/j.molimm.2025.04.016 · Cited by 4 · see citing works

Pulmonary Delivery of Biopharmaceuticals

Andrade, F., Moura, C. C., & Sarmento, B. F. C. C. (2014) · Springer eBooks · doi:10.1007/978-1-4614-9524-6_7 · Cited by 4 · see citing works

Nanomedicine at the Pulmonary Frontier: Immune-Centric Approaches for Respiratory Disease Treatment

Kaur, J. K., Sharma, A., Passi, G., Dey, P., Khajuria, A., Alajangi, H. K., Jaiswal, P. K., Barnwal, R. P., & Singh, G. (2024) · Immunological Investigations · doi:10.1080/08820139.2023.2298398 · Cited by 3 · see citing works

Nanotechnology laying new foundations for combating COVID-19 pandemic

Jain, S., Hussain, A., Bhatt, A., Nasa, A., Navani, N. K., & Mutreja, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90538-1.00019-4 · Cited by 3 · see citing works

Novel vaccination strategies and approaches against human tuberculosis

Méndez‐Samperio, P. (2019) · Scandinavian Journal of Immunology · doi:10.1111/sji.12774 · Cited by 3 · see citing works

Vaccine Preparation

Price, D. N., Kunda, N. K., McBride, A. A., & Muttil, P. (2016) · doi:10.1002/9781118943182.ch4 · Cited by 3 · see citing works

Mucosal delivery of antigen‐coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice

Stylianou, E., Diogo, G. R., Pepponi, I., van Dolleweerd, C. J., Arias, M. A., Locht, C., Rider, C. C., Sibley, L. S., Cutting, S. M., Loxley, A., et al. (2013) · European Journal of Immunology · doi:10.1002/eji.201343887 · Cited by 42 · see citing works

A novel nanoparticle vaccine displaying multistage tuberculosis antigens confers protection in mice infected with H37Rv

Ding, Y., Li, Y., Wu, Z., Zhou, Y., Guo, Y., Tian, S. I. P., Yu, R., Deng, C., Wei, R., Chen, H., et al. (2025) · npj Vaccines · doi:10.1038/s41541-025-01216-8 · Cited by 14 · see citing works

Single-dose Ag85B-ESAT-6 loaded–poly(lactic-co-glycolic acid) nanoparticles confer protective immunity against tuberculosis

Malik, A., Gupta, M. K., Mani, R., & Bhatnagar, R. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s172391 · Cited by 39 · see citing works

Evaluation of PLGA, lipid-PLGA hybrid nanoparticles, and cationic pH-sensitive liposomes as tuberculosis vaccine delivery systems in a Mycobacterium tuberculosis challenge mouse model – A comparison

Szachniewicz, M. M., Neustrup, M. A., van den Eeden, S. J. F., van Meijgaarden, K. E., Franken, K. L. M. C., van Veen, S., Koning, R. I., Limpens, R. W. A. L., Geluk, A., Bouwstra, J. A., et al. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124842 · Cited by 4 · see citing works

Evaluation of adjuvants for a pulmonary vaccine against tuberculosis

Todoroff, J. (2013) · Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B))